NanoVibronix Schedules Virtual Special Stockholder Meeting July 11

TL;DR

**FEED is holding a virtual special meeting on July 11th; shareholders need to vote to shape the company's future.**

AI Summary

NanoVibronix, Inc. (FEED) has filed a Definitive Proxy Statement (DEF 14A) on June 20, 2025, for a Special Meeting of Stockholders to be held virtually on July 11, 2025, at 10:00 a.m. Eastern Time. The meeting will address specific business items, though the filing does not detail revenue or net income figures. The company, incorporated in Delaware with a fiscal year ending December 31, operates in the Orthopedic, Prosthetic & Surgical Appliances & Supplies sector. Stockholders as of May 16, 2025, are eligible to vote, emphasizing the importance of participation to ensure a quorum. The virtual format at www.virtualshareholdermeeting.com/NAOV2025SM2 aims to provide broad access, requiring a 16-digit control number for entry. Key business changes or strategic outlooks are not explicitly detailed in this initial DEF 14A filing, which primarily serves as a notice for the upcoming meeting. Risks are implicitly tied to shareholder engagement and the successful execution of the meeting's agenda.

Why It Matters

This DEF 14A filing signals an upcoming critical juncture for NanoVibronix, Inc. as it convenes a Special Meeting of Stockholders on July 11, 2025. For investors, this meeting will likely address significant corporate actions or proposals that could directly impact share value and governance, making their vote crucial. Employees and customers might see implications depending on the nature of the proposals, which could range from executive compensation to strategic shifts in the orthopedic and surgical supplies market. In a competitive landscape, the outcomes could influence NanoVibronix's ability to innovate and maintain its market position against larger players.

Risk Assessment

Risk Level: low — The risk level is low because this DEF 14A filing is a procedural document announcing a Special Meeting of Stockholders on July 11, 2025. It does not disclose any immediate financial distress or adverse operational changes, but rather facilitates shareholder participation in upcoming decisions. The primary risk is shareholder apathy, potentially hindering quorum achievement for the virtual meeting at www.virtualshareholdermeeting.com/NAOV2025SM2.

Analyst Insight

Investors should carefully review the full proxy statement once available to understand the specific proposals for the July 11, 2025 Special Meeting. Vote your shares promptly, either by proxy card, telephone, or internet, to ensure your voice is heard on critical company matters.

Key Numbers

• July 11, 2025 — Special Meeting Date (Date stockholders will vote on company matters)
• 10:00 a.m. Eastern Time — Meeting Time (Scheduled start time for the virtual Special Meeting)
• May 16, 2025 — Record Date (Eligibility cut-off for voting at the Special Meeting)
• 16-digit — Control Number Length (Required for virtual meeting access and voting)
• 3842 — SIC Code (Standard Industrial Classification for Orthopedic, Prosthetic & Surgical Appliances & Supplies)

Key Players & Entities

• NanoVibronix, Inc. (company) — Registrant filing the DEF 14A
• SEC (regulator) — Securities and Exchange Commission
• July 11, 2025 (date) — Date of the Special Meeting of Stockholders
• May 16, 2025 (date) — Record date for stockholders entitled to vote
• Delaware (state) — State of incorporation for NanoVibronix, Inc.
• 969 Pruitt Ave, Tyler, TX 77569 (address) — Business address of NanoVibronix, Inc.
• (914) 233-3004 (phone_number) — Business phone number of NanoVibronix, Inc.
• 001-36445 (identifier) — SEC File Number for NanoVibronix, Inc.
• 0001326706 (identifier) — Central Index Key (CIK) for NanoVibronix, Inc.
• www.virtualshareholdermeeting.com/NAOV2025SM2 (website) — Virtual meeting platform for the Special Meeting

FAQ

Industry Context

NanoVibronix, Inc. operates within the Orthopedic, Prosthetic & Surgical Appliances & Supplies sector (SIC Code 3842). This industry is characterized by innovation in medical device technology, driven by an aging population and increasing demand for minimally invasive procedures. Competition can be intense, with established players and emerging companies vying for market share through product development and strategic partnerships.

Regulatory Implications

As a medical device company, NanoVibronix is subject to stringent regulatory oversight, primarily from the FDA in the United States and similar bodies internationally. Compliance with quality standards, manufacturing practices, and product approvals is critical. Any changes in regulatory requirements or delays in product approvals could significantly impact the company's operations and market access.

What Investors Should Do

1. Review the Proxy Statement carefully.
2. Vote your shares.
3. Prepare for the virtual meeting.

Key Dates

• 2025-07-11: Special Meeting of Stockholders — Stockholders will vote on company matters, and a quorum is required for business to be conducted.
• 2025-05-16: Record Date — Establishes the list of stockholders eligible to vote at the Special Meeting.
• 2025-06-20: Filing of Definitive Proxy Statement (DEF 14A) — Provides official notice and details regarding the Special Meeting agenda and voting procedures.

Glossary

DEF 14A

A Definitive Proxy Statement filed with the SEC, providing detailed information to shareholders before a meeting where they will vote on corporate matters. (This document is the primary source of information for the upcoming Special Meeting of Stockholders.)

Special Meeting of Stockholders

A meeting called by a company for its shareholders to vote on specific, often significant, corporate actions. (The purpose of this filing is to inform shareholders about and solicit their participation in this meeting.)

Record Date

A specific date set by a company to determine which shareholders are eligible to receive dividends, vote on corporate matters, or receive other distributions. (Determines eligibility to vote at the Special Meeting on July 11, 2025.)

Quorum

The minimum number of shareholders or their proxies required to be present at a meeting for the meeting to be valid and for business to be transacted. (The company emphasizes the importance of voting to ensure a quorum is met for the Special Meeting.)

Virtual Meeting

A meeting conducted online, typically via a webcast, allowing remote participation by shareholders. (The Special Meeting will be held exclusively online, requiring specific access credentials.)

Control Number

A unique identifier provided to shareholders, required to access and vote at a virtual shareholder meeting. (Essential for shareholders to participate in the virtual Special Meeting and cast their votes.)

Year-Over-Year Comparison

This filing is a Definitive Proxy Statement (DEF 14A) for a Special Meeting, not an annual report. Therefore, direct comparisons of financial metrics like revenue, net income, or margins to a previous filing are not possible from this document. The focus is on the procedural aspects of the upcoming shareholder meeting and the specific business items to be addressed, rather than a review of past financial performance.

Filing Details

This Form DEF 14A (Form DEF 14A) was filed with the SEC on June 20, 2025 regarding NanoVibronix, Inc. (FEED).

View full filing on EDGAR

View Full Filing

View this DEF 14A filing on SEC EDGAR